Matches in Wikidata for { <http://www.wikidata.org/entity/Q91509937> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q91509937 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91509937 description "scientific article published on 02 April 2020" @default.
- Q91509937 description "wetenschappelijk artikel" @default.
- Q91509937 description "наукова стаття, опублікована 2 квітня 2020" @default.
- Q91509937 description "գիտական հոդված հրատարակված 2020 թվականի ապրիլի 2-ին" @default.
- Q91509937 name "Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer" @default.
- Q91509937 name "Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer" @default.
- Q91509937 type Item @default.
- Q91509937 label "Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer" @default.
- Q91509937 label "Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer" @default.
- Q91509937 prefLabel "Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer" @default.
- Q91509937 prefLabel "Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer" @default.
- Q91509937 P1433 Q91509937-6A0A46FB-2A2C-4FA3-BF52-2A4E08A97BA9 @default.
- Q91509937 P1476 Q91509937-22526C0F-B908-4D82-A322-CA2A2086F498 @default.
- Q91509937 P2093 Q91509937-0C2AF465-05C4-4AAA-B3CE-5135C2EEC244 @default.
- Q91509937 P2093 Q91509937-1817AF5E-0C27-4E9D-8855-F006D289D7A6 @default.
- Q91509937 P2093 Q91509937-1B0EC6B3-1DE1-4735-B903-9D8268CB8138 @default.
- Q91509937 P2093 Q91509937-37AB96FA-FEAD-4EE0-90D0-0D593CEFB375 @default.
- Q91509937 P2093 Q91509937-38A019A5-20BB-41C6-8513-5898EDFFC125 @default.
- Q91509937 P2093 Q91509937-593C3D10-C22D-4A97-A86F-F56285E2C357 @default.
- Q91509937 P2093 Q91509937-918DFA4A-37F1-48FD-8CF7-EE25FCC5D9CC @default.
- Q91509937 P2093 Q91509937-C7561E7D-64C9-47AA-9332-6C9C8A219329 @default.
- Q91509937 P2093 Q91509937-D1FCAEF1-EE19-4CB9-8122-325AAB54C559 @default.
- Q91509937 P2093 Q91509937-D4BE2865-D325-473E-9081-F88DD8D5BC07 @default.
- Q91509937 P31 Q91509937-404C24D0-A69C-4F81-B803-05B04F7EF9BE @default.
- Q91509937 P356 Q91509937-9AF5727F-EC45-44A6-AC3C-CA33053746CF @default.
- Q91509937 P577 Q91509937-25073940-2FD0-4A88-8543-D349C8E9F5B6 @default.
- Q91509937 P698 Q91509937-476AA62F-73D8-435A-A1D0-EC1DD4A55C68 @default.
- Q91509937 P921 Q91509937-6C209E66-FCC5-4CE8-869F-3873A3F0856F @default.
- Q91509937 P932 Q91509937-D538C710-0B0F-4A36-8291-E2FD8F70B2A7 @default.
- Q91509937 P356 S10549-020-05604-7 @default.
- Q91509937 P698 32240454 @default.
- Q91509937 P1433 Q326085 @default.
- Q91509937 P1476 "Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer" @default.
- Q91509937 P2093 "Christof Vulsteke" @default.
- Q91509937 P2093 "Corina L Martinez-Mena" @default.
- Q91509937 P2093 "Ella Evron" @default.
- Q91509937 P2093 "Georgeta Fried" @default.
- Q91509937 P2093 "Hannelore Denys" @default.
- Q91509937 P2093 "Marc T Martens" @default.
- Q91509937 P2093 "Marie-Pascale L Graas" @default.
- Q91509937 P2093 "Mona M Van Steenberghe" @default.
- Q91509937 P2093 "Noa E Ben-Baruch" @default.
- Q91509937 P2093 "Randal G D'Hondt" @default.
- Q91509937 P31 Q13442814 @default.
- Q91509937 P356 "10.1007/S10549-020-05604-7" @default.
- Q91509937 P577 "2020-04-02T00:00:00Z" @default.
- Q91509937 P698 "32240454" @default.
- Q91509937 P921 Q412616 @default.
- Q91509937 P932 "7182624" @default.